Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results.
Pichota, A., Duraiswamy, J., Yin, Z., Keller, T.H., Alam, J., Liung, S., Lee, G., Ding, M., Wang, G., Chan, W.L., Schreiber, M., Ma, I., Beer, D., Ngew, X., Mukherjee, K., Nanjundappa, M., Teo, J.W., Thayalan, P., Yap, A., Dick, T., Meng, W., Xu, M., Koehn, J., Pan, S.H., Clark, K., Xie, X., Shoen, C., Cynamon, M.(2008) Bioorg Med Chem Lett 18: 6568-6572
- PubMed: 19008098 
- DOI: https://doi.org/10.1016/j.bmcl.2008.10.040
- Primary Citation of Related Structures:  
3E3U - PubMed Abstract: 
Bacterial peptide deformylase (PDF) belongs to a subfamily of metalloproteases catalyzing the removal of the N-terminal formyl group from newly synthesized proteins. We report the synthesis and biological activity of highly potent inhibitors of Mycobacterium tuberculosis (Mtb) PDF enzyme as well as the first X-ray crystal structure of Mtb PDF. Structure-activity relationship and crystallographic data clarified the structural requirements for high enzyme potency and cell based potency. Activities against single and multi-drug-resistant Mtb strains are also reported.
Organizational Affiliation: 
Novartis Institute for Tropical Diseases, 10 Biopolis Road, #05-01 Chromos, Singapore 138670, Singapore. arkadius.pichota@novartis.com